NNC2215, a glucose-sensitive insulin, offers improved glycemic control by dynamically adjusting to blood sugar levels, ...

糖尿病患者在胰岛素治疗过程中，面临低血糖风险的大挑战。为了解决这个难题，科学家们一直在努力开发能够对血糖水平有反馈反应的胰岛素。最近，由NNC2215带来的突破性研究成果引起了大家的关注。NNC2215是一种新型胰岛素共轭体，能够根据环境葡萄糖水平自 ...

Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. Log out ...

Recent clinical trials of weekly insulin highlight how this formulation may be useful in managing diabetes, but the drug has limitations.

USA: A recent analysis from the ONWARDS clinical trials has revealed significant improvements in treatment satisfaction among ...

Tresiba (insulin degludec), a longer-acting insulin, has been shown to be safe and effective in pregnancy, but “there are some concerns in terms of its length of action and its ability to make c ...

Efsitora, a once-weekly insulin injection, is said to reduce the hassle of taking daily doses of diabetes medications like ...

Ryzodeg ® 70/30 contains two types of insulin: Basal insulin called insulin degludec - this has a long blood sugar level lowering effect. Rapid-acting insulin called insulin aspart - this lowers ...

Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. Log out ...

The VBP for insulin – which applies to supplies destined for hospitals in China – is expected to be implemented during the first half of 2022, according to Novo Nordisk.